Pfizer Shares Are Trading Higher Following a Q1 EPS Beat. The Company Reaffirmed Guidance but Said It Is Trending Towards the Upper End of Its 2025 Adjusted Diluted EPS Guidance Range.
Dow Boosted by Honeywell, Sherwin-Williams While S&P and Nasdaq Seesaw
Earnings Call Summary | Regeneron Pharmaceuticals(REGN.US) Q1 2025 Earnings Conference
Regeneron Projects Pivotal Data Readouts for Multiple Programs in 2025
AstraZeneca Outlines $5B Opportunity for Oral PCSK9 Inhibitor With Phase 3 Trials in 2025
4 Stocks to Watch on Tuesday: KO, PFE, GM and UPS